Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 527-531, February 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, Y.
Right arrow Articles by Hein, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, Y.
Right arrow Articles by Hein, D. W.

Acetylator Genotype (NAT2)-dependent Formation of Aberrant Crypts in Congenic Syrian Hamsters Administered 3,2'-Dimethyl-4-aminobiphenyl1

Yi Feng, Rick J. Wagner, Adrian J. Fretland, William K. Becker, A. Marvin Cooley, Theresa P. Pretlow, Kap J. Lee and David W. Hein2

Departments of Pharmacology and Toxicology [Y. F., A. J. F., D. W. H.], Surgery [Y. F., R. J. W., W. K. B.], Pathology [A. M. C.], and Biomedical Research Center [K. J. L.], University of North Dakota School of Medicine, Grand Forks, North Dakota 58202, and Institute of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106 [T. P. P.]

Some but not all human epidemiological studies suggest a higher incidence of colon cancer in rapid acetylator individuals. Aberrant crypts, the earliest morphologically evident preneoplastic lesions in chemical colon carcinogenesis, were measured in rapid and slow acetylator congenic Syrian hamsters administered 3,2'-dimethyl-4-aminobiphenyl, an aromatic amine colon carcinogen, to investigate the specific role of the acetylator genotype (NAT2) in colon carcinogenesis. Age-matched rapid (Bio. 82.73/H-Patr) and slow (Bio. 82.73/H-Pats) acetylator female Syrian hamsters congenic at the NAT2 locus received a s.c. injection of 3,2'-dimethyl-4-aminobiphenyl (100 mg/kg) at the start of weeks 1 and 2. After 10 and 14 weeks, the hamsters were sacrificed, and each whole cecum, colon, and rectum was stained with 0.2% methylene blue, fixed in 4% paraformaldehyde, and examined under a dissecting microscope for the presence of aberrant crypts. Aberrant crypts were identified in the cecums and colons of both rapid and slow acetylator congenic hamsters treated with 3,2'-dimethyl-4-aminobiphenyl but not in vehicle controls. The size of the aberrant crypt foci was larger in the colon than in the cecum, and the highest frequency of aberrant crypt foci was observed in the cecum. No aberrant crypts were detected in the rectum. The frequency of aberrant crypt foci was significantly higher (2–3-fold) in rapid versus slow acetylator congenic hamsters in both cecum (P = 0.0352) and colon (P = 0.0006). These results support human epidemiological studies that suggest the rapid acetylator genotype is associated with higher risk of colon cancer induced by aromatic amines.

1 This study was partially supported by USPHS Grants CA-34627 and CA-48032 (to T. P. P.). A preliminary report of this work was presented at the annual meeting of the American Association for Cancer Research, March, 1995 (57) and the Sixth International Conference on Carcinogenic and Mutagenic N-Substituted Aryl Compounds, November, 1995 (58).

2 To whom requests for reprints should be addressed, at Department of Pharmacology and Toxicology, University of North Dakota School of Medicine, 501 North Columbia Road, Grand Forks, ND 58202-9037.

Received 8/17/95. Accepted 11/29/95.




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. J. Fretland, U. S. Devanaboyina, Y. Feng, M. A. Leff, G. H. Xiao, S. J. Webb, and D. W. Hein
Oral Administration of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Yields PhIP-DNA Adducts but Not Tumors in Male Syrian Hamsters Congenic at the N-acetyltransferase 2 (NAT2) Locus
Toxicol. Sci., February 1, 2001; 59(2): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng
Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
C. D. Davis and Y. Feng
Dietary Copper, Manganese and Iron Affect the Formation of Aberrant Crypts in Colon of Rats Administered 3,2'-Dimethyl-4-Aminobiphenyl
J. Nutr., May 1, 1999; 129(5): 1060 - 1067.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.